393 filings
25-NSE
NMTRQ
9 Meters Biopharma, Inc.
8 Sep 23
Exchange delisting
10:11am
8-K
NMTRQ
9 Meters Biopharma, Inc.
18 Jul 23
Entry into a Material Definitive Agreement
8:00am
8-K
NMTRQ
9 Meters Biopharma, Inc.
16 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:26pm
8-K
NMTRQ
9 Meters Biopharma, Inc.
30 May 23
9 Meters Biopharma Announces Management Change and Provides Clinical Update on Vurolenatide in Patients with Short Bowel Syndrome
4:11pm
8-K
NMTRQ
9 Meters Biopharma, Inc.
22 May 23
Other Events
8:05am
8-K
ntqlaf3 eual15ov1
19 May 23
Entry into a Material Definitive Agreement
8:02am
8-K
qf8r 258d3tpejwhugey
15 May 23
9 Meters Biopharma Provides Business Update and Reports Financial Results for First Quarter 2023
5:16pm
8-K
6u09ohm9m8w2c4w
27 Apr 23
Entry into a Material Definitive Agreement
8:17am
8-K
no7jm48fol
6 Apr 23
Entry into a Material Definitive Agreement
4:15pm
8-K
cim9 lklr
5 Apr 23
9 Meters Biopharma Announces Successful Pre-IND Meeting with FDA Regarding its GIP Antagonist NM-136 for Obesity
8:31am
8-K
2t4f6x ys
28 Mar 23
9 Meters Biopharma Provides Business Update and Reports Financial Results for Fourth Quarter and Full Year 2022
8:03am
8-K
971saa5 dk8k0erkrqt
15 Mar 23
9 Meters Biopharma Announces $5 Million Registered Direct Offering
4:08pm
424B5
xth7d5jqk y40s995a7
15 Mar 23
Prospectus supplement for primary offering
7:39am
8-K
8yd i8oh4d1
13 Mar 23
Other Events
2:40pm
8-K
n5l6gn6
13 Mar 23
Other Events
8:25am
8-K
xi6czprs 7ahhh47
13 Jan 23
Entry into a Material Definitive Agreement
9:05am